Day PM - Search Results

1

Low doses of flagellin-L2 multimer vaccines protect against challenge with diverse papillomavirus genotypes.

Kalnin K, Tibbitts T, Yan Y, Stegalkina S, Shen L, Costa V, Sabharwal R, Anderson SF, Day PM, Christensen N, Schiller JT, Jagu S, Roden RB, Almond J, Kleanthous H. Kalnin K, et al. Among authors: day pm. Vaccine. 2014 Jun 12;32(28):3540-7. doi: 10.1016/j.vaccine.2014.04.032. Epub 2014 Apr 26. Vaccine. 2014. PMID: 24780250 Free PMC article.

2

A human papillomavirus (HPV) in vitro neutralization assay that recapitulates the in vitro process of infection provides a sensitive measure of HPV L2 infection-inhibiting antibodies.

Day PM, Pang YY, Kines RC, Thompson CD, Lowy DR, Schiller JT. Day PM, et al. Clin Vaccine Immunol. 2012 Jul;19(7):1075-82. doi: 10.1128/CVI.00139-12. Epub 2012 May 16. Clin Vaccine Immunol. 2012. PMID: 22593236 Free PMC article.

3

Cell surface-binding motifs of L2 that facilitate papillomavirus infection.

Yang R, Day PM, Yutzy WH 4th, Lin KY, Hung CF, Roden RB. Yang R, et al. Among authors: day pm. J Virol. 2003 Mar;77(6):3531-41. doi: 10.1128/jvi.77.6.3531-3541.2003. J Virol. 2003. PMID: 12610128 Free PMC article.

4

Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection.

Richards RM, Lowy DR, Schiller JT, Day PM. Richards RM, et al. Among authors: day pm. Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1522-7. doi: 10.1073/pnas.0508815103. Epub 2006 Jan 23. Proc Natl Acad Sci U S A. 2006. PMID: 16432208 Free PMC article.

5

Mechanisms of human papillomavirus type 16 neutralization by l2 cross-neutralizing and l1 type-specific antibodies.

Day PM, Gambhira R, Roden RB, Lowy DR, Schiller JT. Day PM, et al. J Virol. 2008 May;82(9):4638-46. doi: 10.1128/JVI.00143-08. Epub 2008 Feb 27. J Virol. 2008. PMID: 18305047 Free PMC article.

6

Role of L2 cysteines in papillomavirus infection and neutralization.

Gambhira R, Jagu S, Karanam B, Day PM, Roden R. Gambhira R, et al. Among authors: day pm. Virol J. 2009 Oct 27;6:176. doi: 10.1186/1743-422X-6-176. Virol J. 2009. PMID: 19860897 Free PMC article.

7

The role of furin in papillomavirus infection.

Day PM, Schiller JT. Day PM, et al. Future Microbiol. 2009 Dec;4(10):1255-62. doi: 10.2217/fmb.09.86. Future Microbiol. 2009. PMID: 19995186 Free PMC article. Review.

8

In vivo mechanisms of vaccine-induced protection against HPV infection.

Day PM, Kines RC, Thompson CD, Jagu S, Roden RB, Lowy DR, Schiller JT. Day PM, et al. Cell Host Microbe. 2010 Sep 16;8(3):260-70. doi: 10.1016/j.chom.2010.08.003. Cell Host Microbe. 2010. PMID: 20833377 Free PMC article.

9

Murine skin and vaginal mucosa are similarly susceptible to infection by pseudovirions of different papillomavirus classifications and species.

Handisurya A, Day PM, Thompson CD, Buck CB, Kwak K, Roden RB, Lowy DR, Schiller JT. Handisurya A, et al. Among authors: day pm. Virology. 2012 Nov 25;433(2):385-94. doi: 10.1016/j.virol.2012.08.035. Epub 2012 Sep 15. Virology. 2012. PMID: 22985477 Free PMC article.

10

Measurement of neutralizing serum antibodies of patients vaccinated with human papillomavirus L1 or L2-based immunogens using furin-cleaved HPV Pseudovirions.

Wang JW, Jagu S, Wang C, Kitchener HC, Daayana S, Stern PL, Pang S, Day PM, Huh WK, Roden RB. Wang JW, et al. Among authors: day pm. PLoS One. 2014 Jul 7;9(7):e101576. doi: 10.1371/journal.pone.0101576. eCollection 2014. PLoS One. 2014. PMID: 24999962 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters